Carregant...

Successful Treatment with Atomoxetine of an Adolescent Boy with Attention Deficit/Hyperactivity Disorder, Extreme Obesity, and Reduced Melanocortin 4 Receptor Function

OBJECTIVE: Recent case reports suggest a link between reduced melanocortinergic tone and both obesity and attention deficit / hyperactivity disorder (ADHD). We present the case of a 13-year-old, male, obese MC4R mutation carrier with ADHD. CASE REPORT: The boy carries a heterozygous mutation in the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Obes Facts
Autors principals: Pott, Wilfried, Albayrak, Özgür, Hinney, Anke, Hebebrand, Johannes, Pauli-Pott, Ursula
Format: Artigo
Idioma:Inglês
Publicat: S. Karger GmbH 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5644743/
https://ncbi.nlm.nih.gov/pubmed/23493066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000348792
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!